vs
Blaize Holdings, Inc.（BZAI）与CUMBERLAND PHARMACEUTICALS INC（CPIX）财务数据对比。点击上方公司名可切换其他公司
Blaize Holdings, Inc.的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.7倍（$23.8M vs $13.7M），CUMBERLAND PHARMACEUTICALS INC净利率更高（-10.3% vs -13.9%，领先3.5%），Blaize Holdings, Inc.同比增速更快（2377500.0% vs 31.1%），CUMBERLAND PHARMACEUTICALS INC自由现金流更多（$3.0K vs $-16.5M）
Blaize Holdings Inc.是一家专注于边缘人工智能计算解决方案的科技企业，主打低能耗AI处理器、低延迟推理软件栈及端到端边缘AI开发工具，核心服务自动驾驶、工业自动化、智慧城市、边缘医疗监测等应用场景。
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
BZAI vs CPIX — 直观对比
营收规模更大
BZAI
是对方的1.7倍
$13.7M
营收增速更快
BZAI
高出2377468.9%
31.1%
净利率更高
CPIX
高出3.5%
-13.9%
自由现金流更多
CPIX
多$16.5M
$-16.5M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.8M | $13.7M |
| 净利润 | $-3.3M | $-1.4M |
| 毛利率 | 10.8% | 83.6% |
| 营业利润率 | -89.8% | -10.0% |
| 净利率 | -13.9% | -10.3% |
| 营收同比 | 2377500.0% | 31.1% |
| 净利润同比 | 50.7% | 25.8% |
| 每股收益（稀释后） | $0.16 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BZAICPIX
| Q4 25 | $23.8M | $13.7M | ||
| Q3 25 | $11.9M | $8.3M | ||
| Q2 25 | — | $10.8M | ||
| Q1 25 | — | $11.7M | ||
| Q4 24 | — | $10.4M | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | — | $9.8M | ||
| Q1 24 | — | $8.5M |
净利润BZAICPIX
| Q4 25 | $-3.3M | $-1.4M | ||
| Q3 25 | $-26.3M | $-1.9M | ||
| Q2 25 | — | $-740.7K | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | — | $-1.5M | ||
| Q2 24 | — | $-1.1M | ||
| Q1 24 | — | $-1.9M |
毛利率BZAICPIX
| Q4 25 | 10.8% | 83.6% | ||
| Q3 25 | 15.0% | 88.1% | ||
| Q2 25 | — | 81.4% | ||
| Q1 25 | — | 87.8% | ||
| Q4 24 | — | 81.1% | ||
| Q3 24 | — | 85.4% | ||
| Q2 24 | — | 82.6% | ||
| Q1 24 | — | 81.5% |
营业利润率BZAICPIX
| Q4 25 | -89.8% | -10.0% | ||
| Q3 25 | -190.3% | -23.7% | ||
| Q2 25 | — | -6.9% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -18.6% | ||
| Q2 24 | — | -10.4% | ||
| Q1 24 | — | -22.0% |
净利率BZAICPIX
| Q4 25 | -13.9% | -10.3% | ||
| Q3 25 | -221.3% | -23.4% | ||
| Q2 25 | — | -6.8% | ||
| Q1 25 | — | 10.7% | ||
| Q4 24 | — | -18.2% | ||
| Q3 24 | — | -17.0% | ||
| Q2 24 | — | -11.0% | ||
| Q1 24 | — | -22.9% |
每股收益（稀释后）BZAICPIX
| Q4 25 | $0.16 | $-0.09 | ||
| Q3 25 | $-0.25 | $-0.13 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | — | $-0.11 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $45.8M | $11.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.0M | $24.9M |
| 总资产 | $102.2M | $76.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BZAICPIX
| Q4 25 | $45.8M | $11.4M | ||
| Q3 25 | $24.0M | $15.2M | ||
| Q2 25 | — | $16.1M | ||
| Q1 25 | — | $15.1M | ||
| Q4 24 | — | $18.0M | ||
| Q3 24 | — | $17.5M | ||
| Q2 24 | — | $17.3M | ||
| Q1 24 | — | $18.5M |
股东权益BZAICPIX
| Q4 25 | $39.0M | $24.9M | ||
| Q3 25 | $1.3M | $26.1M | ||
| Q2 25 | — | $28.0M | ||
| Q1 25 | — | $28.7M | ||
| Q4 24 | — | $22.9M | ||
| Q3 24 | — | $24.8M | ||
| Q2 24 | — | $26.3M | ||
| Q1 24 | — | $27.5M |
总资产BZAICPIX
| Q4 25 | $102.2M | $76.8M | ||
| Q3 25 | $60.9M | $65.9M | ||
| Q2 25 | — | $67.9M | ||
| Q1 25 | — | $69.9M | ||
| Q4 24 | — | $75.6M | ||
| Q3 24 | — | $76.7M | ||
| Q2 24 | — | $78.5M | ||
| Q1 24 | — | $81.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-16.5M | $3.0K |
| 自由现金流经营现金流 - 资本支出 | $-16.5M | $3.0K |
| 自由现金流率自由现金流/营收 | -69.6% | 0.0% |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $4.8M |
8季度趋势，按日历期对齐
经营现金流BZAICPIX
| Q4 25 | $-16.5M | $3.0K | ||
| Q3 25 | $-24.9M | $187.2K | ||
| Q2 25 | — | $843.8K | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $475.5K | ||
| Q2 24 | — | $-855.7K | ||
| Q1 24 | — | $-2.1M |
自由现金流BZAICPIX
| Q4 25 | $-16.5M | $3.0K | ||
| Q3 25 | $-24.9M | $163.4K | ||
| Q2 25 | — | $817.3K | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $460.1K | ||
| Q2 24 | — | $-862.8K | ||
| Q1 24 | — | $-2.2M |
自由现金流率BZAICPIX
| Q4 25 | -69.6% | 0.0% | ||
| Q3 25 | -210.2% | 2.0% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 32.9% | ||
| Q4 24 | — | 18.2% | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | -8.8% | ||
| Q1 24 | — | -25.6% |
资本支出强度BZAICPIX
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.2% | 0.3% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.5% |
现金转化率BZAICPIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.10× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
